• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Schroder UK Equity Fund Z Income

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund ProviderSchroder Unit Trusts Limited
Fund SummaryThe Fund aims to provide capital growth and income in excess of the FTSE All Share (Gross Total Return) index (after fees have been deducted) over a three to five year period by investing in equity and equity related securities of UK companies.
SEDOL codeB44B299
ISINGB00B44B2999
Fund codeSZUEI
ManagersAlex Breese
Manager Tenure7 years
Morningstar CategoryUK Large-Cap Equity
IMA SectorUK All Companies
Fund Size£307 million
Fund TypeOEIC
Management StyleActive
Ongoing Charge Figure (OCF)0.91%
Cavendish ongoing charge0.05%
FundsNetwork Service Fee0.20%
Minimum Initial Investment£25
Minimum Top Up£25
Minimum Monthly Investment£25
Sell Price£0.5302
Buy Price£0.5302
Price Change+2.7321%
Price Date28th September 2020
Yield3.69%
Dividend FrequencySemi-Annually
ISA EligibleYes
SIPP EligibleYes
Inception Date3rd December 2012
Fund StatusOPEN
Alex Breese is a UK Equity Fund Manager at Schroders, responsible for managing the Schroder UK Equity Fund and ISF UK Equity Funds. He joined Schroders in 2013 and is based in London. Alex was a Fund Manager, Head of UK Equities and Investment Director at Neptune Investment Management from 2005 to 2013, managing the Neptune UK Special Situations Fund from 2006. Alex was also Assistant Fund Manager of the Neptune Income and Neptune Quarterly Income Funds. He joined Neptune as an investment analyst in 2005. Prior to joining Neptune, Alex gained nearly three years experience as an engineering consultant Qualifications: CFA Charterholder; MEng in Mechanical Engineering from Cardiff University.

3-year Mean Monthly Return: -0.558%

Annual Returns2019201820172016201520142013201220112010
Fund Performance-19.94%-5.71%+5.96%+22.58%-4.03%+7.82%+15.83%+24.58%-4.06%+26.91%
Benchmark Performance
(UK Large-Cap Equity)
-12.42%-0.54%+7.78%+19.70%-1.91%
Time PeriodCumulativeBenchmark Performance
(UK Large-Cap Equity)
Fund Compared to Benchmark
1 day2.73%-19.05%+21.78%
1 week1.40%-1.36%+2.76%
1 month-3.71%-2.55%-1.15%
3 months-7.34%+11.32%-18.66%
6 months2.09%-15.33%+17.42%
1 year-26.27%-2.95%-23.31%
3 years-9.08%+2.82%-11.90%
5 years-1.23%+5.09%-6.32%
10 years3.72%-1.35%+5.07%
YTD-30.32%+1.84%-32.17%
Since inception10.24%Currently unavailableCurrently unavailable

Top 10 shares for this fund

Share NameCountryValue
GlaxoSmithKline PLCGBR6.64%
Tesco PLCGBR6.44%
Anglo American PLCGBR4.93%
BP PLCGBR4.59%
Standard Chartered PLCGBR4.20%
Imperial Brands PLCGBR4.08%
WPP PLCGBR3.61%
Aviva PLCGBR3.57%
Smiths Group PLCGBR3.45%
Sanofi SAFRA3.44%
Dividend DatePer share amountReinvestment Price
22nd June 20200.0083£0.5757
23rd December 20190.0116£0.7790
21st June 20190.0147£0.7341
21st December 20180.0107£0.6951
21st June 20180.0123£0.8014
21st December 20170.0087£0.7722